Nu Skin Enterprises, Inc.
NUS
$4.79
$0.091.92%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.44B | 1.49B | 1.56B | 1.63B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38B | 1.44B | 1.49B | 1.56B | 1.63B |
| Cost of Revenue | 423.76M | 442.38M | 453.76M | 473.03M | 494.22M |
| Gross Profit | 951.49M | 998.90M | 1.03B | 1.09B | 1.13B |
| SG&A Expenses | 881.19M | 917.37M | 940.52M | 988.14M | 1.04B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30B | 1.36B | 1.39B | 1.46B | 1.53B |
| Operating Income | 70.31M | 81.53M | 90.88M | 99.23M | 95.82M |
| Income Before Tax | -26.39M | 64.20M | 196.20M | 120.20M | 117.51M |
| Income Tax Expenses | 190.00M | 9.67M | 35.99M | 10.60M | 16.68M |
| Earnings from Continuing Operations | -216.39 | 54.53 | 160.20 | 109.61 | 100.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -216.39M | 54.53M | 160.20M | 109.61M | 100.83M |
| EBIT | 70.31M | 81.53M | 90.88M | 99.23M | 95.82M |
| EBITDA | 120.31M | 131.93M | 143.14M | 155.03M | 156.85M |
| EPS Basic | -4.46 | 1.11 | 3.23 | 2.21 | 2.03 |
| Normalized Basic EPS | 0.69 | 0.83 | 0.92 | 1.39 | 1.00 |
| EPS Diluted | -4.48 | 1.09 | 3.19 | 2.18 | 2.01 |
| Normalized Diluted EPS | 0.68 | 0.83 | 0.91 | 1.38 | 1.00 |
| Average Basic Shares Outstanding | 194.78M | 195.62M | 197.18M | 198.32M | 198.62M |
| Average Diluted Shares Outstanding | 198.24M | 199.14M | 200.05M | 199.85M | 199.27M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | -5.39% | 21.47% | 7.39% | 10.87% | 11.83% |